Tổng số lượt xem trang

Thứ Ba, 21 tháng 2, 2012

Papillary Carcinoma từ mô giáp lạc chỗ trong tủy sống

Xin giới thiệu một tạp chí nội tiết mới của Asean. Đó là tạp chí JAFES (Journal of the ASEAN Federation of Endocrine Societies). Website là http://asean-endocrinejournal.org/. Tạp chí này mới được thành lập và tuyên bố từ hôm Hội nghị AFES 16 ở TP Hồ Chí Minh tháng 11-2011 vừa qua.

Bài về mô tuyến giáp lạc chỗ ung thư hoá sau được trích từ tạp chí nội tiết học trên: JAFES, Vol 26 n0 2, November, 2011.




Introduction

Thyroid tissue in an ectopic location is rare, occurring in 1 out of 100,000 to 300,000 persons; and is usually found in the lateral neck. Ectopic thyroid tissue developing axially is even more rare, with up to 90% of cases being lingual thyroid tissue arising embryologically from a median anlage from the pharyngeal floor. Very rarely, ectopic thyroid tissue may give rise to a carcinoma.

Carcinogenesis of ectopic thyroid tissue located in midline structures such as lingual thyroid and thyroglossal duct cysts, have a reported incidence of approximately 1%, and usually occurs during the third decade of life. Almost all cases are diagnosed post-surgically on histopathologic examination. Management of these cases is individualized.


Presentation

A 12-year old girl developed progressive bilateral lower extremity weakness and sensory deficit, difficulty in ambulation, and bowel and bladder incontinence in 2004.

She had no known exposure to ionizing radiation. Maternal and early pediatric histories were unremarkable. She had no family history of malignancy and thyroid disease. Physical examination revealed a lean build; with vital signs, height and weight appropriate for age. The thyroid gland was not enlarged. Chest and abdominal examination were unremarkable. She had full and equal pulses without peripheral edema. Neuromuscular examination revealed decreased manual muscle strength on the lower extremities, hypoesthesia from T4 dermatomal level and hyperreflexia on both lower extremities. Magnetic resonance imaging (MRI) of the thoracolumbar spine revealed a well-defined enhancing nodule in the spinal cord at the level of T3-T4. The nodule measured 1.16 cm x 1.26 cm x 1.58 cm, with intermediate signal intensity in both T1- and T2-weighted studies, with associated edema above and below the lesion from level T2 down to T8-T9 (Figure 1).


She underwent a T3-T4 laminectomy with tumor excision 3 months after initial consult (January 2005). Histopathologic exam revealed a 3.0 cm x 1.5 cm x 0.8 cm mass, microscopically composed of bland cuboidal cells with uniform ovoid nuclei and adequate amphophilic cytoplasm arranged in pseudorosettes, with some cells exhibiting pale-staining to grayish cytoplasm and rare mitotic figures (Figure 2).



Immunohistochemical staining for cytokeratin and neuron-specific enolase were positive. Ependymoma was considered in the histopathologic report of the excised mass. Two months postoperatively, the patient had gradual improvement of lower extremity weakness and was able to ambulate by herself. She was then lost to follow up.

However, in March 2009, the patient developed gradual progressive weakness of both lower extremities, leading to paralysis. A repeat MRI of the thoracic spine showed an avidly enhancing intramedullary nodule at T3-T4 level, appearing bilobed with irregular margins, measuring 1.13 cm x 1.65 cm x 1.63 cm. The nodule was slightly hyperintense in T1-weighted study (Figure 3) and hypointense on T2-weighted imaging, with some extension to the neural canal at the level of T3-T4.


A second laminectomy with tumor excision was done in May 2009. Histopathologic examination of the excised 2 cm x 1.5 cm x 0.5 cm mass revealed colloid material within the lumen of follicles or ducts (Figure 4) with papillary architecture and nuclear features consistent with papillary carcinoma. These findings were not seen in the histopathologic examination of the first surgical specimen.



Microscopic sections from the second surgical specimen stained positively for thyroglobulin, thyroid transcription factor-1 (TTF-1) and epithelial membrane antigen (EMA) (Figures 5 to 7). The pathologic diagnosis of papillary carcinoma, suggestive of a thyroid primary, supersedes the previous histopathologic diagnosis. Thyroid ultrasound was normal. Thyroid function testing was also normal: thyroid stimulating hormone (TSH) was 1.03 µIU/mL (normal value 0.35 to 4.94), total thyroxine was 9 µg/dL (normal value 4.9 to 11.7), and total triiodothyronine was 1.24 ng/mL (normal value 0.58 to 1.59). Metastatic workup including CT scans of the neck, chest and abdomen did not reveal any metastatic foci.



Papillary carcinoma of the thyroid with spinal cord metastasis was the foremost consideration. A total thyroidectomy was performed in July 2009, to confirm occult primary thyroid cancer and to facilitate ablation of residual thyroid tissue for subsequent surveillance for recurrence using radioactive iodine. Histopathologic examination of the thyroid gland revealed nodular hyperplasia after thorough sampling of the entire specimen. Two months after total thyroidectomy, whole body scan using 2 mCi Iodine-131 revealed functioning thyroid remnants in the anterior neck without undue tracer deposition seen elsewhere. Her postoperative stimulated thyroglobulin level was less than 2 ng/mL. She was placed on daily levothyroxine suppressive doses with regular monitoring of thyroid function tests and thyroglobulin level. Radioactive iodine ablation was not indicated since there was no evidence of remaining iodine-avid lesions in the spinal cord. She was placed on physical therapy and rehabilitation program after spinal surgery and thyroidectomy. The patient, now 19 years of age, remains paraplegic, with no evidence of active malignancy both clinically and on imaging studies, two years since her last surgery. Thyrotropin levels are adequately suppressed and serial results of thyroglobulin levels are undetectable.

Discussion
Thyroid tissue that is located elsewhere from its expected location anterior to the second to fourth tracheal cartilages is ectopic. Embryologically, the thyroid gland develops from a median anlage and a pair of lateral anlages. The embryologic pharyngeal floor gives rise to the median anlage, whereas the fourth and fifth branchial pouches give rise to the lateral anlage. Its descent follows the heart and great vessels and moves caudally from its origin to its location in the neck in front of the trachea. Aberrant caudal descent of the median anlage during development may give rise to an intrathoracic location of ectopic thyroid tissue. There have been reports of ectopic thyroid tissue occurring in the right ventricle of the heart, aberrant right carotid thyroid tissue, carotid bifurcation, lingual ectopic thyroid, intrathoracic ectopic thyroid, substernal goiter, intralaryngotracheal thyroid and spinal cord. Carcinomas arising from ectopic thyroid tissue are uncommon. They have been reported to arise from thyroid tissue in thyroglossal duct cysts, lateral aberrant thyroid tissue, lingual thyroid and mediastinal and struma ovarii. Most tumors in the ectopic locations have been papillary carcinomas, mixed follicular and papillary carcinomas or Hürthle cell tumors. However, a carcinoma arising from spinal ectopic thyroid tissue has never been reported in literature.


Differentiating between a metastatic thyroid carcinoma and malignant transformation of an ectopic thyroid tissue is difficult and can only be done after surgery, as in this case. There are no clinical, biochemical, or imaging parameters that may assist in determining the nature of the lesion; and histological examination is always required for definitive diagnosis. True ectopic thyroid tissue has an arterial supply independent of the cervical arteries that supply the thyroid; the cervical thyroid gland is normal or absent with no history of surgery; the cervical thyroid gland does not have a similar pathologic process as the ectopic tumor, and there is no history or evidence of thyroid malignancy. Although a metastatic papillary thyroid cancer was initially considered, the migration of papillary carcinoma from a primary thyroid to distant sites bypassing cervical lymph nodes is unusual. Also, a review of the post-thyroidectomy histopathology did not reveal malignancy in the thyroid, leading us to conclude that the tumor excised from the patient’s spinal cord was ectopic thyroid tissue that transformed into papillary carcinoma. The postoperative whole body scan that was negative for iodine avid lesions outside the thyroid bed may reflect either complete resection of tumor in the spinal cord or poor iodine avidity. She did not receive high dose radioiodine ablation, and was given a suppressive levothyroxine dose at 100 mcg daily to prevent recurrence.

Conclusion

Metastasis from a primary thyroid carcinoma must first be ruled out before considering malignant transformation of an ectopic thyroid tissue, which is a rare occurrence. There are no clinical, biochemical, or imaging parameters that may assist in determining the nature of these lesions, and histological exam is required for definitive diagnosis.

Surgical excision is the treatment of choice. Post-surgical management includes thyrotropin suppression to prevent recurrence. Radioiodine ablation was not thought to be necessary in this case, as there was no evidence of remaining iodine-avid lesions in the spinal cord.
__________________

ECTOPIC THYROID in MEDIC CENTER, HCMC, Vietnam

CASE 1
Ectopic Lingual Thyroid, Le van Tai, Nguyen Thien Hung, Medic Medical Center, HCMC, Vietnam





We report the case of a 36 year-old female patient who presents with symptoms of dysphonia (hot potato speech) due to abnormal mass at the base of the tongue. Ultrasound detects no thyroid gland at the normal site. At the base of the tongue, there is an hypoechoic mass without hypervascularity on color Doppler, which is suspected for ectopic thyroid tissue. Then Tc99m sodium pertechnetate scanning shows thyroid tissue at the base of tongue and there is no thyroid tissue in the normal location.


CASE 2:

2 Focal Ectopic Thyroid, Jasmine Thanh Xuan, Ng Thien Hung, Phan Thanh Son, Medic Medical Center

A 50 yo female patient was detected randomly with a small nodule at the base of her tongue per ENT endoscopy. This nodule does not appear on neck ultrasound but an another mass was found at hyoid region by ultrasound: solid, echo poor, well vascularization, and no thyroid gland detected at the normal site. At last, on MDCT 64, the 2 ectopic thyroid focals were revealed, one at the base of the tongue and the other, at thyrohyoid membrane.






Thứ Sáu, 17 tháng 2, 2012

SIÊU ÂM ĐIỀU TRỊ RUN / nucleus ventralis intermedius of thalamus

Nhân bụng trung gian của đồi thị=nhận nhiều phần các bó chiếu để phân biệt từ bán cầu tiểu não đối bên (qua cuống tiểu não trên) và cầu nhạt cùng bên; hầu như toàn bộ các nhân chiếu của vỏ não vận động.
Nhân bụng trung gian của đồi thị là mục tiêu của thủ thuật xác định trong không gian chuyên biệt để điều trị chứng run, ngoài cách dùng thuốc, như deep brain stimulation, conventional thalamotomy, và gamma knife thalamotomy.

MRI hướng dẫn siêu âm tập trung điều trị (dùng cho u não trước đây) chứng run là cách điều trị mới hơn hẵn gamma knife thalamotomy vì an toàn hơn (không tia xạ).

Siêu âm được tập trung vào nhân bụng trung gian của đồi thị. Để xác định mục tiêu đích, bệnh nhân phải vẽ những vòng xoắn. Bệnh nhân nam đầu tiên 74 tuổi bị run tay P 10 năm, không thể viết được tên mình. Khi bác sĩ chạm đúng target, tay bệnh nhân giảm run, và những vòng xoắn  được vẽ đẹp hơn. Lúc bấy giờ cường độ được tăng lên với hàng ngàn chùm siêu âm hội tụ lại để đốt huỷ mô bệnh là những tế bào gây run, gọi là tạo tổn thương. Tổn thương của bệnh nhân này chỉ có 4mm đường kính.

Máy sử dụng có tên ExAblate Neuro của InSightec Ltd, cung cấp năng lượng siêu âm tập trung để huỷ mô đích, và quá trình huỷ bằng nhiệt này được theo dõi bằng MRI.

Còn trong phòng hồi sức, bệnh nhân đã có thể cầm ly nước bằng tay P mà không đổ vãi. Sau 1 tháng tay bệnh nhân không bị tái phát run.

----------------------------
nucleus ventralis intermedius of thalamus= the composite middle third of the ventral nucleus receiving in its various parts distinctive projections from the contralateral half of the cerebellum (by way of the superior cerebellar peduncle) and the ipsilateral globus pallidus; nearly all parts of the nucleus project to the motor cortex.


Nucleus ventralis intermedius thalami, the relay of cerebellar afferences, is the target of stereotactians particularly for the improvement of tremor.
Focused Deep Brain Ultrasonography Promising for Essential Tremor (ET)
Megan Brooks, March 30, 2011

Magnetic resonance (MR)–guided focused ultrasonography has been successfully used to relieve a 74-year-old man's debilitating essential tremor (ET) affecting his dominant right hand.

Uncontrollable shaking left the patient unable to use his right hand for more than a decade. After MR-guided focused ultrasonography, "the tremor was gone," W. Jeffrey Elias, MD, a neurosurgeon at the University of Virginia (UVA) in Charlottesville, noted in an interview with Medscape Medical News. "In the recovery room, he used his right hand to drink from a cup without spilling," Dr. Elias added in a UVA-issued statement. The patient has now been followed up for 1 month and he "continues to do well," Dr. Elias said. His tremor has not returned.

The ultrasonography is focused on the ventralis intermedius nucleus of the thalamus. "This is a standard trimmer target; whether we use radiofrequency thalamotomy or thalamic deep brain stimulation, we target a similar place," Dr. Elias explained.

To find their target, the team had the patient draw spirals during the procedure. At first, his hand shook violently, but as the researchers honed in on their target, the shaking subsided and his spirals became smooth. At that point, they increased the sound waves to heat and destroy the tissue, a process called "lesioning," Dr. Elias said. This particular patient's lesion was 4 mm in diameter.

This therapy is delivered with the ExAblate Neuro system from InSightec Ltd. The device delivers focused ultrasound energy to the targeted site, and the thermal destruction is monitored in real time with MR imaging (MRI).

Currently available treatments for ET outside drug therapy include deep brain stimulation, conventional thalamotomy, and gamma knife thalamotomy.
An "advantage of this new procedure [previously used to treat brain tumors] compared to gamma knife is that there is no radiation involved and thus it seems to be a safer procedure," Dr. Moro said.
"It might be superior to gamma knife thalamotomy and thus be a good treatment for tremor patients who cannot have deep brain stimulation or do not want to have an invasive treatment," she added. Only time will tell. 
"By demonstrating that MR-guided focused ultrasound can safely and effectively treat tissue deep in the brain with great precision and accuracy, we will open the door for treating a variety of conditions, such as Parkinson's disease, brain tumors, and epilepsy.